Alex Boshart

Alex Boshart

Auto-generated profile, based on publicly available information

Alex Boshart

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAlex Boshart
Alex Boshart
SFSofia Farkona
Sofia Farkona
SRShravanthi Rajasekar
Shravanthi Rajasekar
CPChiara Pastrello
Chiara Pastrello
MAMaya Allen
Maya Allen
AKAna Konvalinka
Ana Konvalinka
Microvascular inflammation and endothelial injury, triggered by interferon-gamma (IFNγ), are hallmarks of antibody-mediated rejection (ABMR), the leading cause of premature kidney allograft loss. Glomerular extracellular matrix (ECM) remodeling and endothelial caveolae formation are important aspects of chronic ABMR. We found galectin-1, an immunomodulatory protein that interacts with the ECM, to be increased in the glomeruli of patients with ABMR, while its gene ( LGALS1 ) expression was decreased by IFNγ stimulation in glomerular endothelial cells. Mechanisms underlying endothelial dysfunction in ABMR, its links to ECM remodeling, and the role of immunomodulatory proteins such as galectin-1 remain incompletely understood. Here we studied the effects of galectin-1 modulation in glomerular microvascular endothelial cells (GMECs) in vitro . We demonstrated that galectin-1 was mainly expressed by glomerular endothelial cells in ABMR kidneys. To model key aspects of endothelial injury in ABMR, we knocked down LGALS1 in GMECs, followed by stimulation with IFNγ and performed label-free quantitative proteomic and phosphoproteomic profiling of GMECs. Proteomic analysis identified 5446 proteins (FDR<0.01), of which 236, 827, and 267 were differentially expressed in response to LGALS1 knockdown, IFNγ treatment, and their interaction, respectively (FDR<0.05). Both LGALS1 knockdown and the interaction between treatments significantly altered expression of adhesion proteins (FDR<0.01), particularly integrin subunit β5, which was validated. Phosphoproteomic profiling identified 2727 phosphopeptides (FDR<0.01), with 28 that were differentially expressed across LGALS1 knockdown, IFNγ treatment, and their interaction (P<0.01). Phosphorylation of CAVN1 and co-localization with its partner CAV1, critical for caveolar formation, were decreased in GMECs upon LGALS1 knockdown, IFNγ stimulation, or both. In a microfluidic model of the glomerular microvasculature, addition of recombinant galectin-1 increased both endothelial permeability and secretion of proinflammatory cytokines, in LGALS1 -silenced GMECs. Thus, endothelial signaling pathways regulated by inflammatory cues and galectin-1 contribute to endothelial injury and caveolae formation, highlighting galectin-1 as a potential therapeutic target in ABMR. Synopsis: Galectin-1 is expressed by kidney glomerular endothelium. This study reveals that modifying galectin-1 in endothelial cells, in the presence of IFNγ perturbs cytoskeletal, adhesion and caveolar proteins resulting in altered endothelial permeability. LGALS1 knockdown increased ECM proteins and decreased interferon-induced proteins. LGALS1 knockdown and IFNγ treatment perturbed cell adhesion proteins such as ITGB5. CAVN1 phosphorylation and colocalization with CAV1 decreased upon LGALS1 knockdown. Extracellular galectin-1 increased microvascular permeability in response to IFNγ.

27 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TCTrirupa Chakraborty
Trirupa Chakraborty
DBDivya Bhakta
Divya Bhakta
ASAnushka Saha
Anushka Saha
CMCamila Macedo
Camila Macedo
DZDaqiang Zhao
Daqiang Zhao
JDJishnu Das
Jishnu Das
Antibody-mediated rejection (AbMR), driven by donor-specific alloantibodies (DSAs), is a major cause of late-stage kidney allograft failure, leading to premature graft loss in over half of affected patients. Despite efforts to link DSA features (e.g., HLA-specific IgG titers) to rejection risk, the immune mechanisms distinguishing DSA+ patients who develop AbMR remain unclear. In this first-in-class study, we develop a sample-sparing and cost-effective technique to generate the most comprehensive biophysical profile of DSAs reported to date. Further, given the complex pathological context and heterogeneity of samples we use a novel interpretable machine learning algorithm to learn signatures reflecting putative causal mechanisms of transplant rejection. We identify distinct mechanistically informative signatures at early and late times post-transplant. These antibody signatures, reflecting both quality and quantity of the humoral response, successfully discriminate DSA+ patients with and without AbMR. In addition to recapitulating known features of AbMR, our analyses reveal a significant and previously underappreciated role for IgM responses and glycosylation patterns, including sialylation and galactosylation, in both early and late rejection. Our identified signatures hold across two independent and geographically distinct cohorts. Leveraging biomedical and computational innovation, we resolve prior inconsistencies in the field by implementing an unbiased systems framework identifying biophysical trends. These trends include selective enrichment of class I HLA-specific IgM and class II HLA-specific IgG responses in late and early rejection, respectively, which were overlooked earlier due to assay and methodological limitations. Corresponding functional relevance of putative causal signatures is further supported by observations from a murine model of chronic rejection, where we observe a significant increase in serum IgM-DSA associated with high risk of rejection as compared to serum IgG-DSA, warranting further exploration into the role of IgM in AbMR. Finally, addressing the lack of a comprehensive approach for pre-diagnosis of late AbMR patients reflecting the complex pathology of late AbMR and heterogeneity of samples (with time post-transplant ranging from 1-10 years), we formulate a risk score from our signatures. This composite risk score, combining IgM and sialylation metrics robustly predicts late AbMR with high sensitivity and specificity, offering a clinically actionable tool for early risk stratification. Together, leveraging our innovative pipeline we show the distinct roles of antibody isotypes/subclasses and glycosylation in disease progression, with IgM and glycosylation signatures showing strong diagnostic and prognostic value. Ultimately, the modularity of approach establishes a generalizable framework for understanding a plethora of complex immune-mediated tissue injury contexts beyond kidney transplantation.

16 July 2026 in bioRxiv
Verified
Preprint
Open access
AWAnthony Wu
Anthony Wu
DKDevon Kohler
Devon Kohler
PNPruthvi Prakash Navada
Pruthvi Prakash Navada
JRJulia E Robbins
Julia E Robbins
GBGabriel E Boyle
Gabriel E Boyle
OVOlga Vitek
Olga Vitek
A common outcome of quantitative mass spectrometry-based proteomic and phosphoproteomic experiments is a list of proteins that are differentially abundant between conditions. However, biological interpretation requires evaluation in the context of prior knowledge of biological mechanisms and protein function. One approach to facilitate mechanistic biological interpretation is to integrate such lists with biological network databases, built from manually curated resources and text mining systems. This manuscript automates this process with MSstatsBioNet, a Bioconductor package that integrates MSstats, a family of open-source packages for detecting differentially abundant proteins, and INDRA, a system that extracts biomolecular networks from biomedical literature using text mining and merges those networks with the content of curated knowledge bases. Taking as input a list of differentially abundant proteins from MSstats, MSstatsBioNet retrieves a protein subnetwork from INDRA and overlays experimental fold changes onto the underlying subnetwork. Users can then interact with the network and overlaid data, interrogating primary literature evidence to construct granular mechanistic narratives for iterative hypothesis generation. We demonstrate the utility of this approach with three case studies, two measuring changes in protein abundance and one measuring changes in phosphorylation.

13 August 2026 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
KMKieran P. Manion
Kieran P. Manion
MAMaya A. Allen
Maya A. Allen
AVAugusta Vincent
Augusta Vincent
SCSergi Clotet-Freixas
Sergi Clotet-Freixas
CPChiara Pastrello
Chiara Pastrello
AKAna Konvalinka
Ana Konvalinka
Key Points: DSA + kidney grafts with antibody-mediated rejection had higher glomerular and tubulointerstitial complement protein levels than those with donor-specific antibodies but no rejection. DSA + patients without rejection lacked accommodation but showed preserved podocyte and tubular protein expression compared with antibody-mediated rejection. Elevated complement and decreased mitochondrial proteins were associated with death-censored allograft loss in DSA + patients with antibody-mediated rejection. Background: Antibody-mediated rejection (AMR) is the main driver of late kidney allograft loss. Anti-HLA donor-specific antibodies (DSAs) are strongly associated with AMR. However, 30%–60% of DSA + patients do not develop AMR, raising the possibility of local tissue adaptations to DSAs. Methods: We performed unbiased proteomic analysis on glomeruli and tubulointerstitium isolated using laser-capture microdissection from the kidney biopsies of 116 DSA + kidney transplant recipients with Banff-classified active AMR, chronic active AMR, mixed AMR, or no rejection. The Significant Latent factor Interaction Discovery and Exploration (SLIDE) machine learning algorithm was used to identify latent factors linked to graft loss among patients with AMR. Results: We quantified 1917 glomerular and 2758 tubulointerstitial proteins by mass spectrometry, with 127 glomerular and 389 tubulointerstitial proteins significantly differentially expressed between all 4 patient groups (one-way ANOVA P < 0.05, Tukey false discovery rate <0.05). In glomeruli, chronic active AMR had the most differentially expressed proteins, consisting primarily of complement and basement membrane components. Tubulointerstitial terminal complement proteins were also significantly increased in chronic active AMR but did not correlate with C4d deposition. Mixed AMR contained the most differentially expressed proteins in the tubulointerstitium, which were linked to IFNγ-associated immune activation, stress responses, and mitochondrial metabolism. DSA + biopsies without rejection were characterized by preservation of podocyte and tubular proteins in glomeruli and tubulointerstitium, respectively, but did not show conventional markers of accommodation. SLIDE identified 3 latent factors from the glomerular proteome and 4 from the tubulointerstitial proteome that significantly distinguished AMR patients with and without graft loss, correlated significantly with allograft injury, and improved prediction of graft loss beyond standard clinical variables in a multivariable risk model. Top proteins within the glomerular SLIDE model included complement components, while top proteins for the tubulointerstitial SLIDE model included tubular and mitochondrial proteins. Conclusions: AMR and graft loss after kidney transplantation were defined by compartment-specific disruptions in complement and mitochondrial proteins.

4 September 2026 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
ABAlex Boshart
Alex Boshart
SFSofia Farkona
Sofia Farkona
SRShravanthi Rajasekar
Shravanthi Rajasekar
CPChiara Pastrello
Chiara Pastrello
MAMaya Allen
Maya Allen
AKAna Konvalinka
Ana Konvalinka